← Dashboard
Aug 31, 2026 04:31 AM ET
Catalyst
FDA/Bio
REVOLUTION MEDICINES: STRONG BUY RASONQUE FDA APPROVAL AND ZOLDONRASIB PDAC EXPANSIONS - SEEKINGALPHA
FDA approval and zoldonrasib PDAC expansions drive strong buy thesis.
What changed
Why it matters
FDA approval and zoldonrasib PDAC expansions drive strong buy thesis.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →
← Dashboard
Aug 31, 2026 04:31 AM ET